Researcher biography

Helen's interest in immune cell interactions across the tissue landscape started during her Master's and PhD with Dr. Ali Zaid at the Menzies Health Institute, Griffith University. Her PhD focused on defining the role of Interleukin-17 in virus-induced arthritis and exploring immunomodulation as a means of dampening synovial inflammation and damage. There, she was able to specialise in 3D imaging on optically-cleared tissues and high-dimensional flow cytometry. Helen received her PhD in 2022, before immediately starting a Postdoc position under Dr. Emma Gordon and Dr. Larisa Labzin at the Institute for Molecular Biosciences, University of Queensland. Her current research focuses on vascular complications in acute and long COVID-19. Specifically, Helen is developing a novel triple-culture model under air-liquid interface to investigate endothelial dysfunction and explore potential therapeutics in COVID-19.